Atlas Trials

Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma

Clinical trial NCT00847522 · COMPLETED

Trial details

NCT number
NCT00847522
Sponsor
University of Utah
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cancer
Start date
2009-02-01
Primary completion
2016-07-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.